These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 27557508)
1. RhoGDIα suppresses self-renewal and tumorigenesis of glioma stem cells. Wu F; Hu P; Li D; Hu Y; Qi Y; Yin B; Jiang T; Yuan J; Han W; Peng X Oncotarget; 2016 Sep; 7(38):61619-61629. PubMed ID: 27557508 [TBL] [Abstract][Full Text] [Related]
2. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970 [TBL] [Abstract][Full Text] [Related]
3. Rho GDP dissociation inhibitor α silencing attenuates silicosis by inhibiting RhoA/Rho kinase signalling. Wei Z; Xu H; Zhang Y; Yi X; Yang X; Chen Y; Mao N; Li S; Xu D; Li S; Zhang H; Li D; Zhang G; Zhang B; Jin F; Gao X; Cai W; Zhang L; Wang R; Yang F Exp Cell Res; 2019 Jul; 380(2):131-140. PubMed ID: 31029634 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway. Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056 [TBL] [Abstract][Full Text] [Related]
5. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801 [TBL] [Abstract][Full Text] [Related]
6. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013 [TBL] [Abstract][Full Text] [Related]
7. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting. Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells. Zhu J; Wang H; Fan Y; Hu Y; Ji X; Sun Q; Liu H Oncol Rep; 2014 Sep; 32(3):1170-8. PubMed ID: 25017049 [TBL] [Abstract][Full Text] [Related]
9. E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability. Jiang X; You H; Niu Y; Ding Y; Chen Z; Wang H; Xu Y; Zhou P; Wei L; Deng D; Xue L; Peng Y; Yang Y; Fan L; Shao N Cancer Lett; 2024 Jul; 593():216875. PubMed ID: 38643837 [TBL] [Abstract][Full Text] [Related]
10. RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis. Giang Ho TT; Stultiens A; Dubail J; Lapière CM; Nusgens BV; Colige AC; Deroanne CF Mol Biol Cell; 2011 Sep; 22(17):3263-75. PubMed ID: 21757538 [TBL] [Abstract][Full Text] [Related]
11. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells. Yoon CH; Hyun KH; Kim RK; Lee H; Lim EJ; Chung HY; An S; Park MJ; Suh Y; Kim MJ; Lee SJ FEBS Lett; 2011 Jul; 585(14):2331-8. PubMed ID: 21704033 [TBL] [Abstract][Full Text] [Related]
12. SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells. Cao Z; Li X; Li J; Kang B; Chen J; Luo W; Huang C Mol Oncol; 2014 Mar; 8(2):285-96. PubMed ID: 24342356 [TBL] [Abstract][Full Text] [Related]
13. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis. Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407 [TBL] [Abstract][Full Text] [Related]
14. Nrf2 is required to maintain the self-renewal of glioma stem cells. Zhu J; Wang H; Sun Q; Ji X; Zhu L; Cong Z; Zhou Y; Liu H; Zhou M BMC Cancer; 2013 Aug; 13():380. PubMed ID: 23937621 [TBL] [Abstract][Full Text] [Related]
15. ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells. Wee B; Pietras A; Ozawa T; Bazzoli E; Podlaha O; Antczak C; Westermark B; Nelander S; Uhrbom L; Forsberg-Nilsson K; Djaballah H; Michor F; Holland EC Sci Rep; 2016 Jul; 6():25956. PubMed ID: 27456282 [TBL] [Abstract][Full Text] [Related]
16. Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer. Huang D; Lu W; Zou S; Wang H; Jiang Y; Zhang X; Li P; Songyang Z; Wang L; Wang J; Huang J; Fang L Cancer Sci; 2017 Jul; 108(7):1293-1302. PubMed ID: 28417530 [TBL] [Abstract][Full Text] [Related]
17. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc. Kim EJ; Kim SH; Jin X; Jin X; Kim H Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381 [TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits. Ma B; Zhang L; Zou Y; He R; Wu Q; Han C; Zhang B J Exp Clin Cancer Res; 2019 Jan; 38(1):23. PubMed ID: 30658712 [TBL] [Abstract][Full Text] [Related]
19. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells. Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells. Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]